VANDA PHARMACEUTICALS INC (VNDA)
US9216591084 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -4.94M | 2.51M | 6.30M | 33.20M | 23.30M | |||
| Depreciation Amortization | 4.53M | 3.01M | 2.70M | 2.90M | 2.90M | |||
| Income Taxes - Deferred | -3.53M | -1.29M | 1.10M | 6.70M | 6.20M | |||
| Change In Working Capital | -15.77M | -747.00K | 6.10M | 2.70M | 4.30M | |||
| Taxes Paid | N/A | 3.60M | N/A | N/A | N/A | |||
| Other non cash items | 8.27M | 9.31M | 15.80M | 18.70M | 15.10M | |||
| OPERATING CASH FLOW | -11.43M | 12.80M | 32.00M | 64.20M | 51.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -290.00K | -383.00K | -700.00K | -600.00K | -1.80M | |||
| Other Investing Activity | -217.18M | -11.67M | 50.60M | -76.10M | -39.70M | |||
| INVESTING CASH FLOW | -217.57M | -12.06M | 49.90M | -76.70M | -41.50M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | N/A | 0.00 | 700.00K | 3.60M | 5.60M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | N/A | 0.00 | 700.00K | 3.60M | 5.60M | |||
| Exchange Rate Effect | 33.00K | 47.00K | 300.00K | -100.00K | 100.00K | |||
| CHANGE IN CASH | -228.97M | 792.00K | 82.90M | -9.00M | 16.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -11.43M | 12.80M | 32.00M | 64.20M | 51.80M | |||
| Capital Expenditure | -290.00K | -383.00K | -700.00K | -600.00K | -1.80M | |||
| FREE CASH FLOW | -11.72M | 12.42M | 31.30M | 63.60M | 50.00M | |||
All data in USD